Precision Genomics Medicine Biobank
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIntermountain Health Care, Inc.
About this trial
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosed with any healthcare-related condition(s)
Subject presenting to an Intermountain Healthcare facility
Male and female adults (≥ 18 years of age)
Reportedly healthy (i.e., non-diseased)
Disqualifiers
Inability or refusal of the patient and/or the patient's legally-acceptable representative to provide informed consent for any reason
Other conditions that the Principal Investigators or Co-Investigators believe may increase the risk to the subject and/or compromise the scientific integrity of the registry
Trial population
Any subject (i.e., diseased or non-diseased) presenting to an Intermountain Healthcare facility.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100,000 Participants
are grouped into 2 trial groupsGroup A: Diseased
Group B: Non-diseased
Trial outcomes
Primary outcomes
1
Biobank for precision genomics
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining genetic and genomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Time frame
Day 02
Biobank for precision transcriptomics
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining transcriptomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Time frame
Day 03
Biobank for precision proteomics
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining proteomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Time frame
Day 0Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov